ARHGAP33

Rho GTPase activating protein 33, the group of Rho GTPase activating proteins

Basic information

Region (hg38): 19:35774532-35788822

Previous symbols: [ "SNX26" ]

Links

ENSG00000004777NCBI:115703OMIM:614902HGNC:23085Uniprot:O14559AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • complex neurodevelopmental disorder (Limited), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ARHGAP33 gene.

  • not_specified (160 variants)
  • not_provided (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGAP33 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001366178.1. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
3
clinvar
6
missense
154
clinvar
5
clinvar
159
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 154 8 3
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ARHGAP33protein_codingprotein_codingENST00000314737 2114291
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.02860.9711257010461257470.000183
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.805767110.8100.00004687016
Missense in Polyphen171193.490.883752036
Synonymous-0.2763103041.020.00001982532
Loss of Function5.031453.90.2600.00000310529

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005890.000565
Ashkenazi Jewish0.00009950.0000992
East Asian0.0001700.000163
Finnish0.00004620.0000462
European (Non-Finnish)0.0001730.000167
Middle Eastern0.0001700.000163
South Asian0.0001310.000131
Other0.0004970.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be involved in several stages of intracellular trafficking. Could play an important role in the regulation of glucose transport by insulin. May act as a downstream effector of RHOQ/TC10 in the regulation of insulin-stimulated glucose transport (By similarity). {ECO:0000250}.;
Pathway
Insulin Signaling;Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases (Consensus)

Recessive Scores

pRec
0.133

Intolerance Scores

loftool
0.678
rvis_EVS
-1.46
rvis_percentile_EVS
3.86

Haploinsufficiency Scores

pHI
0.402
hipred
Y
hipred_score
0.595
ghis
0.671

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Arhgap33
Phenotype
embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
small GTPase mediated signal transduction;response to toxic substance;protein transport;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;regulation of dendritic spine morphogenesis
Cellular component
cytoplasm;cytosol;plasma membrane;protein-containing complex;dendritic spine
Molecular function
GTPase activator activity;protein binding;protein kinase binding;phosphatidylinositol binding